Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004564137 | SCV000562599 | likely benign | Familial adenomatous polyposis 1 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001027316 | SCV001189855 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001027316 | SCV001346975 | likely benign | Hereditary cancer-predisposing syndrome | 2020-02-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002210 | SCV004835781 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004564137 | SCV005082012 | benign | Familial adenomatous polyposis 1 | 2024-04-15 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |